KC
About
Kan Chen currently serves as a partner at Qiming Venture Partners. Before joining Qiming Venture Partners, Kan was a senior scientist at Johnson&Johnson discovering innovative cancer medicine. Prior to that, Kan was a group leader at Jiangsu Hengrui Medicine, developing new cancer immunotherapies. Kan earned his Ph.D. degree in Cell Biology from Case Western Reserve University in the U.S. and finished his postdoctoral training in Immunology at Harvard Medical School. He got his bachelor’s degree in biological sciences from Fudan University.
Position in the VCSift Database
- • 17 investors at Qiming Venture Partners are tracked.
- • 2,531 investors hold the Partner role in VCSift. Kan Chen is one of them.
- • 1,032 investors are based in Seattle, Washington, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Seattle, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Kan
Search Investors